公司產(chǎn)品僅用于科研專業(yè)供應(yīng)的抗體,是用于化學(xué)反應(yīng)、分析化驗(yàn)、研究實(shí)驗(yàn)、教學(xué)實(shí)驗(yàn)、化學(xué)配方使用的純凈化學(xué)品,價(jià)格實(shí)惠,多種規(guī)格供應(yīng),售后完善。
英文名稱: PRKCB
中文名稱: 蛋白激酶C beta 1/2抗體
規(guī)格:50ul、100ul、200ul
別 名:PKC beta 1 + PKC beta 2; PKCB; PKC B; PKCB1; PKCB2; PRKCB; PRKCB I; PRKCB II; PRKCB1; PRKCB2; Protein kinase C beta 1; Protein kinase C beta 2; Protein kinase C beta; PKC beta 1; PKC beta 2; KPCB_HUMAN; MGC41878; PKC beta; PKC-B; PKC-beta; PRKC B; PRKC B1; Protein kinase C beta 1; Protein kinase C beta; Protein kinase C beta type.
研究領(lǐng)域:細(xì)胞生物 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶
抗體來(lái)源:Rabbit
克隆類型:Polyclonal
交叉反應(yīng):Human, Mouse, Rat, (predicted: Pig, Cow, Rabbit, )
產(chǎn)品應(yīng)用:WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:ug/Test IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量:74kDa
細(xì)胞定位:細(xì)胞核 細(xì)胞漿 細(xì)胞膜
性 狀:Liquid
濃 度:1mg/ml
免 疫 原:KLH conjugated synthetic peptide derived from human PKC beta 1: 601-673/673
亞 型:IgG
純化方法:affinity purified by Protein A
緩 沖 液:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項(xiàng):This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹:Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role. The protein encoded by this gene is one of the PKC family members. It is a calcium-independent and phospholipid-dependent protein kinase. This kinase is important for T-cell activation. It is required for the activation of the transcription factors NF-kappaB and AP-1, and may link the T cell receptor (TCR) signaling complex to the activation of the transcription factors.
Calcium-activated and phospholipid-dependent serine/threonine-protein kinase involved in various processes such as regulation of the B-cell receptor (BCR) signalosome, apoptosis and transcription regulation. Plays a key role in B-cell activation and function by regulating BCR-induced NF-kappa-B activation and B-cell suvival. Required for recruitment and activation of the IKK kinase to lipid rafts and mediates phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652', leading to activate the NF-kappa-B signaling. Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. Also involved in triglyceride homeostasis. Serves as the receptor for phorbol esters, a class of tumor promoters.
抗體基本結(jié)構(gòu):
抗體制備過(guò)程:
1.材料與試劑
a.提取的動(dòng)物 Ig
b.弗氏佐劑和弗氏不佐劑
d.實(shí)驗(yàn)動(dòng)物 兔
e.其它材料及試劑
2、選擇實(shí)驗(yàn)活體。
3、進(jìn)行動(dòng)物免疫實(shí)驗(yàn)。
4、試取血樣進(jìn)行測(cè)試,查看免疫效果。
5、如果免疫成功,殺死實(shí)驗(yàn)活體,采集全部血清。
6、純化出抗體。
7、鑒定抗體。胎牛血清(無(wú)菌采制)
免疫熒光技術(shù)的實(shí)驗(yàn)步驟:
一、準(zhǔn)備好試劑與儀器:
磷酸鹽緩沖鹽水、熒光標(biāo)記的抗體溶液、緩沖甘油、搪瓷桶三只、有蓋搪瓷盒一只、熒光顯微鏡、玻片架、濾紙、37℃溫箱等。
二、實(shí)驗(yàn)步驟
1.滴加0.01mol/L,pH7.4的PBS于待檢標(biāo)本片上,十分鐘后棄去,使標(biāo)本保持一定濕度。
2.滴加適當(dāng)稀釋的熒光標(biāo)記的抗體溶液,使其覆蓋標(biāo)本,置于有蓋搪瓷盒內(nèi),保溫一定時(shí)間以三十分鐘為參考。
3.取出玻片,置玻片架上,先用0.01mol/L,pH7.4的PBS沖洗后,再按順序過(guò)0.01mol/L,pH7.4的PBS三缸浸泡,每缸三到五分鐘,并不停地?fù)u晃振蕩。
4.取出玻片,用濾紙吸去多余水分,但不使標(biāo)本干燥,加一滴緩沖甘油,以蓋玻片覆蓋。
5.立即用熒光顯微鏡觀察。觀察標(biāo)本的特異性熒光強(qiáng)度。
抗體的定義:
抗體(antibody),(免疫球蛋白不僅僅只是抗體)是一種由漿細(xì)胞(效應(yīng)B細(xì)胞)分泌,被免疫系統(tǒng)用來(lái)鑒別與中和外來(lái)物質(zhì)如細(xì)菌、病毒等的大型Y形蛋白質(zhì),僅被發(fā)現(xiàn)存在于脊椎動(dòng)物的血液等體液中,及其B細(xì)胞的細(xì)胞膜表面??贵w能識(shí)別特定外來(lái)物的一個(gè)特征,該外來(lái)目標(biāo)被稱為抗原。
動(dòng)物抗體功能分類:
①豬抗體:豬瘟抗體,豬藍(lán)耳抗體,豬圓環(huán)病毒抗體,豬偽狂犬抗體,豬細(xì)小病毒抗體,豬口蹄疫抗體,豬流感抗體等。
②禽抗體:小鵝瘟抗體,鴨肝抗體抗體,鴨漿膜炎抗體,抗體,新城疫抗體等
③牛抗體:??谔阋呖贵w,奶牛乳房炎抗體,牛流行熱抗體,牛病毒性腹瀉抗體,牛出血性敗血癥抗體等
④羊抗體:羊痘抗體,羊口蹄疫抗體,羊小反芻獸疫抗體,羊快疫抗體,羊腸毒血癥抗體,羊猝疽抗體,羊黑疫抗體等。
⑤犬抗體:犬狂犬病抗體、犬瘟熱抗體、犬副流感抗體、犬腺病毒抗體與犬細(xì)小病毒病抗體,狐貉水貂的偽狂犬抗體、細(xì)小病毒抗體、乙腦抗體等。
抗體的結(jié)構(gòu):
抗體是具有4條多肽鏈的對(duì)稱結(jié)構(gòu),其中2條較長(zhǎng)、相對(duì)分子量較大的相同的重鏈(H鏈);2條較短、相對(duì)分子量較小的相同的輕鏈(L鏈)。鏈間由二硫鍵和非共價(jià)鍵聯(lián)結(jié)形成一個(gè)由4條多肽鏈構(gòu)成的單體分子。輕鏈有κ和λ兩種,重鏈有μ、δ、γ、ε和α五種。 整個(gè)抗體分子可分為恒定區(qū)和可變區(qū)兩部分。在給定的物種中,不同抗體分子的恒定區(qū)都具有相同的或幾乎相同的氨基酸序列。可變區(qū)位于"Y"的兩臂末端。在可變區(qū)內(nèi)有一小部分氨基酸殘基變化特別強(qiáng)烈,這些氨基酸的殘基組成和排列順序更易發(fā)生變異區(qū)域稱高變區(qū)。高變區(qū)位于分子表面,最多由17個(gè)氨基酸殘基構(gòu)成,少則只有2 ~ 3個(gè)。高變區(qū)氨基酸序列決定了該抗體結(jié)合抗原抗原的特異性。一個(gè)抗體分子上的兩個(gè)抗原結(jié)合部位是相同的,位于兩臂末端稱抗原結(jié)合片段(antigen-binding fragment, Fab)。"Y"的柄部稱結(jié)晶片段(crystalline fragment,FC),糖結(jié)合在FC 上。
公司出售的產(chǎn)品:
丙酮suan脫氫meiE2封閉多肽 | 人細(xì)胞色suP450(CYP450)試劑盒ELISA | 鴨瘟病毒PCR試劑盒 |
3-磷suan甘油醛脫氫mei(內(nèi)參)封閉多肽 | 人抗Mi2抗體(anti-Mi2-Ab)ELISA試劑盒 | 凋亡抑制蛋白Survivin基因PCR檢測(cè)試劑盒 |
轉(zhuǎn)化生長(zhǎng)因子β調(diào)節(jié)蛋白4封閉多肽 | 人髓鞘相關(guān)糖蛋白抗體(MAG Ab)檢測(cè)試劑盒elisa | 杜氏利什曼蟲(chóng)黑熱病病原蟲(chóng)PCR檢測(cè)試劑盒 |
4號(hào)染色體開(kāi)放閱讀框40封閉多肽 | 大鼠絨毛膜促性腺激su(CG)ELISA Kit | 鴨腸炎病毒PCR試劑盒 |
氧化蛋白質(zhì)水解mei封閉多肽 | 田鼠痘病毒PCR試劑盒 | 小鼠乳腺瘤病毒PCR檢測(cè)試劑盒 |
磷suan化蛋白激meiC亞型G封閉多肽 | 禽白血病病毒E亞群RT-PCR試劑盒 | 乳頭狀瘤病毒抗體IgGELISA試劑盒 |
N-鈣粘附分子封閉多肽 | 米德?tīng)柋げ《?/span>PCR檢測(cè)試劑盒 | Janus激mei1ELISA試劑盒 |
鳥(niǎo)氨suan氨甲?;€粒體封閉多肽 | 陰道加德納菌PCR檢測(cè)試劑盒 | 抗風(fēng)疹病毒IgM抗體ELISA試劑盒 |
緊密連接蛋白1封閉多肽 | 蛋白激酶C beta 1/2抗體對(duì)蝦桿狀病毒PCR試劑盒 | K-乙酰轉(zhuǎn)移mei5ELISA試劑盒 |
應(yīng)激誘導(dǎo)磷蛋白1封閉多肽 | 腺病毒C型PCR試劑盒 | Nesprin1蛋白ELISA試劑盒 |
©2024 上海莼試生物技術(shù)有限公司 版權(quán)所有 備案號(hào):滬ICP備17029297號(hào)-3 技術(shù)支持:化工儀器網(wǎng) GoogleSitemap 總訪問(wèn)量:106118 管理登陸